These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 8634421
1. A bicistronic therapeutic retroviral vector enables sorting of transduced CD34+ cells and corrects the enzyme deficiency in cells from Gaucher patients. Medin JA, Migita M, Pawliuk R, Jacobson S, Amiri M, Kluepfel-Stahl S, Brady RO, Humphries RK, Karlsson S. Blood; 1996 Mar 01; 87(5):1754-62. PubMed ID: 8634421 [Abstract] [Full Text] [Related]
2. Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors. Migita M, Medin JA, Pawliuk R, Jacobson S, Nagle JW, Anderson S, Amiri M, Humphries RK, Karlsson S. Proc Natl Acad Sci U S A; 1995 Dec 19; 92(26):12075-9. PubMed ID: 8618847 [Abstract] [Full Text] [Related]
3. Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer. Conneally E, Bardy P, Eaves CJ, Thomas T, Chappel S, Shpall EJ, Humphries RK. Blood; 1996 Jan 15; 87(2):456-64. PubMed ID: 8555466 [Abstract] [Full Text] [Related]
4. Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol. Xu L, Stahl SK, Dave HP, Schiffmann R, Correll PH, Kessler S, Karlsson S. Exp Hematol; 1994 Feb 15; 22(2):223-30. PubMed ID: 8299741 [Abstract] [Full Text] [Related]
5. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation. Dunbar CE, Kohn DB, Schiffmann R, Barton NW, Nolta JA, Esplin JA, Pensiero M, Long Z, Lockey C, Emmons RV, Csik S, Leitman S, Krebs CB, Carter C, Brady RO, Karlsson S. Hum Gene Ther; 1998 Nov 20; 9(17):2629-40. PubMed ID: 9853529 [Abstract] [Full Text] [Related]
6. Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow. Nolta JA, Yu XJ, Bahner I, Kohn DB. J Clin Invest; 1992 Aug 20; 90(2):342-8. PubMed ID: 1379609 [Abstract] [Full Text] [Related]
7. Correction of glucocerebrosidase deficiency after retroviral-mediated gene transfer into hematopoietic progenitor cells from patients with Gaucher disease. Fink JK, Correll PH, Perry LK, Brady RO, Karlsson S. Proc Natl Acad Sci U S A; 1990 Mar 20; 87(6):2334-8. PubMed ID: 2315324 [Abstract] [Full Text] [Related]
8. Retroviral vector design for long-term expression in murine hematopoietic cells in vivo. Correll PH, Colilla S, Karlsson S. Blood; 1994 Sep 15; 84(6):1812-22. PubMed ID: 8080986 [Abstract] [Full Text] [Related]
10. Detection and isolation of gene-corrected cells in Gaucher disease via a fluorescence-activated cell sorter assay for lysosomal glucocerebrosidase activity. Lorincz M, Herzenberg LA, Diwu Z, Barranger JA, Kerr WG. Blood; 1997 May 01; 89(9):3412-20. PubMed ID: 9129049 [Abstract] [Full Text] [Related]
11. Growth factors and stromal support generate very efficient retroviral transduction of peripheral blood CD34+ cells from Gaucher patients. Xu LC, Kluepfel-Stahl S, Blanco M, Schiffmann R, Dunbar C, Karlsson S. Blood; 1995 Jul 01; 86(1):141-6. PubMed ID: 7540881 [Abstract] [Full Text] [Related]
12. The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease. Wells S, Malik P, Pensiero M, Kohn DB, Nolta JA. Gene Ther; 1995 Oct 01; 2(8):512-20. PubMed ID: 8593601 [Abstract] [Full Text] [Related]
13. Transduction of fibroblasts and CD34+ progenitors using a selectable retroviral vector containing cDNAs encoding arylsulfatase A and CD24. Tsutsudaasano A, Migita M, Takahashi K, Shimada T. J Hum Genet; 2000 Oct 01; 45(1):18-23. PubMed ID: 10697958 [Abstract] [Full Text] [Related]
14. Complete restoration of glucocerebrosidase deficiency in Gaucher fibroblasts using a bicistronic MDR retrovirus and a new selection strategy. Aran JM, Licht T, Gottesman MM, Pastan I. Hum Gene Ther; 1996 Nov 10; 7(17):2165-75. PubMed ID: 8934230 [Abstract] [Full Text] [Related]
15. Delayed targeting of cytokine-nonresponsive human bone marrow CD34(+) cells with retrovirus-mediated gene transfer enhances transduction efficiency and long-term expression of transduced genes. Veena P, Traycoff CM, Williams DA, McMahel J, Rice S, Cornetta K, Srour EF. Blood; 1998 May 15; 91(10):3693-701. PubMed ID: 9573006 [Abstract] [Full Text] [Related]
17. Transduction of mobilized peripheral blood CD34+ cells with the glucocerebrosidase cDNA. Nimgaonkar MT, Bahnson AB, Boggs SS, Ball ED, Barranger JA. Gene Ther; 1994 May 15; 1(3):201-7. PubMed ID: 7584082 [Abstract] [Full Text] [Related]
18. Cytokine mobilization of peripheral blood stem cells in patients with Gaucher disease with a view to gene therapy. Nimgaonkar M, Mierski J, Beeler M, Kemp A, Lancia J, Mannion-Henderson J, Mohney T, Bahnson A, Rice E, Ball ED. Exp Hematol; 1995 Dec 15; 23(14):1633-41. PubMed ID: 8542958 [Abstract] [Full Text] [Related]
19. Retroviral mediated transfer of the cDNA for human glucocerebrosidase into hematopoietic stem cells of patients with Gaucher disease. A phase I study. Dunbar C, Kohn D. Hum Gene Ther; 1996 Jan 20; 7(2):231-53. PubMed ID: 8788174 [Abstract] [Full Text] [Related]
20. Comparison of methods for retroviral mediated transfer of glucocerebrosidase gene to CD34+ hematopoietic progenitor cells. Takiyama N, Mohney T, Swaney W, Bahnson AB, Rice E, Beeler M, Scheirer-Fochler S, Ball ED, Barranger JA. Eur J Haematol; 1998 Jul 20; 61(1):1-6. PubMed ID: 9688285 [Abstract] [Full Text] [Related] Page: [Next] [New Search]